Serological responses and protection levels in chickens administered with Newcastle disease vaccines
- Author:
Geumji SEUNG
1
;
Jiye KIM
;
Hyobi KIM
;
Ji-Yeon KIM
;
Yang-Ho JANG
;
Yeon-Hee KIM
;
Moon HER
;
Seong-Joon YI
;
Keun-Woo LEE
;
Il JANG
;
Young Ju LEE
Author Information
- Publication Type:Original Article
- From:Korean Journal of Veterinary Research 2022;62(4):e29-
- CountryRepublic of Korea
- Language:English
- Abstract: Vaccination against Newcastle disease (ND) is the most effective means of controlling the disease, and these vaccines are commercialized only after their safety and effectiveness have been verified through tests that comply with Korean Standards of National Lot Release for Veterinary Biologics. This study investigated whether a relatively convenient and safe serological test can be used in place of the challenge test using highly virulent ND virus. Hemagglutination inhibition (HI) assay and enzyme-linked immunosorbent assay (ELISA) were considered positive of log2 2 or more and cutoff value of 200 or more, respectively, in both live and inactivated vaccines. However, when the antibody levels of the live and inactivated vaccines induced using the Ulster 2C, KBNP-C4152R2L, and K148/08 strains were compared, the antibody titers for inactivated vaccines were significantly higher than those for live vaccines in both the HI assay and ELISA. A strong positive correlation was observed between HI and ELISA antibody titers. The live vaccines corresponded to a survival rates of ≥ 80% and the inactivated vaccines corresponded to 100% survival rates. This study confirmed that standard efficacy tests can serve as serological tests, and can replace the challenge test and that the vaccine approval process can be improved.
